• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Oncology

Compression sleeves used prophylactically decrease arm swelling after breast cancer surgery

byKassandra McFarlaneandSamuel Chan
February 7, 2022
in Dermatology, Oncology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Compression sleeves reduced and delayed the incidence of lymphedema in the first year after surgery

2. Quality of life measures were not significantly different between the compression sleeve group and the control group

Evidence Rating Level: 2 (Good)

Study Rundown: Lymphedema in the arm(s) after axillary lymph node dissection (ALND) as part of breast cancer treatment is common. This study aimed to determine whether compression sleeve usage prophylactically would decrease the incidence of swelling during the year following breast cancer treatment as compared with standard post-treatment care. The impact on quality of life was also explored. The incidence of arm swelling was greater in the control group (80 of 149) as compared to the compression group (58 of 152). No significant differences were detected between either group with respect to quality-of-life measures. Limitations to this study include its small sample size as well as its inability to project whether the reduced incidence and delayed onset of lymphedema will result in decreased breast cancer related lymphedema in the future. This study plans to follow the participants prospectively in order to address this limitation of applicability. Overall, the prophylactic use of compression sleeves after axillary lymph node dissection for breast cancer treatment appears to reduce the incidence and delays the onset of upper extremity lymphedema.

Click to read the study in the Journal of Clinical Oncology

Relevant Reading: A brief summary of the consensus discussion on customizing therapies for women with early breast cancer

In-Depth [randomized controlled trial]: This single-blind, stratified randomized controlled trial study conducted in Mubai, India included 307 adult women randomly allocated to either the control group (n=152) or the compression group (n=154); 149 control group participants and 152 compression group participants were included in the analysis. Primary study outcomes were the incidence of arm swelling and secondary outcomes included impact on quality of life. The incidence of arm swelling was less in the compression group (58 of 152) than in the control group (80 of 149) (HR = 0.61; 95% confidence interval (CI), 0.43 to 0.85). At 1 year, the estimated cumulative incidence of lymphedema was 52% in the control group (95% CI, 44% to 61%) compared to 42% in the compression group (95% CI, 34% to 51%). Quality of life measures were not significantly different between the two groups.

RELATED REPORTS

#VisualAbstract: Internal mammary node irradiation improves survival for patients with centromedially located node-positive breast cancer

#VisualAbstract: Exemestane plus etinostat does not improve survival compared to exemestane alone for HR⁺ advanced breast cancer

#VisualAbstract: Implant-based breast reconstruction with acellular dermal matrix does not reduce reoperation rates

Image: PD

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: ALNDbreast cancer survivalLymphedema
Previous Post

Molnupiravir does not improve clinical outcomes in patients hospitalized with COVID-19

Next Post

United States veterans experiencing homelessness may have difficulty accessing secure messaging from providers

RelatedReports

#VisualAbstract: Internal mammary node irradiation improves survival for patients with centromedially located node-positive breast cancer
StudyGraphics

#VisualAbstract: Internal mammary node irradiation improves survival for patients with centromedially located node-positive breast cancer

November 9, 2021
#VisualAbstract: Exemestane plus etinostat does not improve survival compared to exemestane alone for HR⁺ advanced breast cancer
StudyGraphics

#VisualAbstract: Exemestane plus etinostat does not improve survival compared to exemestane alone for HR⁺ advanced breast cancer

November 8, 2021
#VisualAbstract: Implant-based breast reconstruction with acellular dermal matrix does not reduce reoperation rates
StudyGraphics

#VisualAbstract: Implant-based breast reconstruction with acellular dermal matrix does not reduce reoperation rates

October 26, 2021
#VisualAbstract: Addition of everolimus to letrozole improves survival in patients with HR⁺ breast cancer and disease progression on tamoxifen
StudyGraphics

#VisualAbstract: Addition of everolimus to letrozole improves survival in patients with HR⁺ breast cancer and disease progression on tamoxifen

October 13, 2021
Next Post
2 Minute Medicine Rewind October 21, 2019

United States veterans experiencing homelessness may have difficulty accessing secure messaging from providers

Study finds increased incidence of new-onset Type 1 Diabetes in children during COVID-19 pandemic

Increased diabetes risk observed in gout patients

Allopurinol does not increased mortality in gout and chronic kidney disease patients

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

Get 2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • #VisualAbstract: Bimekizumab shows a favourable 2-year safety profile in patients with moderate to severe plaque psoriasis
  • Medical cannabis provides little improvement to sleep in chronic pain patients
  • Alzheimer disease in individuals with Down syndrome has similar variability in age of onset and mortality rate as autosomal dominant forms
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.